Zepp Health (ZEPP) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Zepp Health reported a revenue of $42.5 million for Q3 2024, marking a 48.9% drop from the previous year, largely due to supply constraints and reduced sales of Xiaomi wearables. Despite a net loss, the company achieved the highest gross margin in its history, driven by successful new product launches like the Amazfit T-Rex 3. Zepp’s strategic focus on innovation and expanding its product line positions it for potential recovery and sustained growth.
For further insights into ZEPP stock, check out TipRanks’ Stock Analysis page.
